[1. Tsuang MT, Faraone SV, Glatt SJ. Schizophrenia, 3rd ed. New York, NY: Oxford University Press, 2011.]Search in Google Scholar
[2. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a metaanalysis of twin studies. Arch Gen Psychiatry. 2003; 60(12): 1187-1192.10.1001/archpsyc.60.12.1187]Search in Google Scholar
[3. Stilo SA, Murray RM. The epidemiology of schizophrenia: replacing dogma with knowledge. Dialogues Clin Neurosci. 2010; 12(3): 305-315.10.31887/DCNS.2010.12.3/sstilo]Search in Google Scholar
[4. van Os J, Kapur S. Schizophrenia. Lancet. 2009; 374(9690): 635-645.10.1016/S0140-6736(09)60995-8]Search in Google Scholar
[5. Turck CW, Maccarrone G, Sayan-Ayata E, Jacob AM, Ditzen C, Kronsbein H, et al. The quest for brain disorder biomarkers. J Med Invest. 2005; 52(Suppl): 231-235.10.2152/jmi.52.23116366504]Search in Google Scholar
[6. Bird A. Perceptions of epigenetics. Nature. 2007; 447(7143): 396-398.10.1038/nature0591317522671]Search in Google Scholar
[7. Bird AP. CpG-rich islands and the function of DNA methylation. Nature. 1986; 321(6067): 209-213.10.1038/321209a02423876]Search in Google Scholar
[8. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA. 2008; 299(24): 2877-2883.10.1001/jama.299.24.2877258189818577732]Search in Google Scholar
[9. Jones PA. Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012; 13(7): 484-492.10.1038/nrg323022641018]Search in Google Scholar
[10. Moore LD, Le T, Fan G. DNA Methylation and its basic function. Neuropsychopharmacology. 2013; 38(1): 23-38.10.1038/npp.2012.112352196422781841]Search in Google Scholar
[11. Rakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, Graf S, et al. An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res. 2008; 18(9): 1518-1529.10.1101/gr.077479.108252770718577705]Search in Google Scholar
[12. Connor CM, Akbarian S. DNA methylation changes in schizophrenia and bipolar disorder. Epigenetics. 2008; 3(2): 55-58.10.4161/epi.3.2.593818398310]Search in Google Scholar
[13. Betcheva ET, Mushiroda T, Takahashi A, Kubo M, Karachanak SK, Zaharieva IT, et al. Casecontrol association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet. 2009; 54(2): 98-107.10.1038/jhg.2008.1419158809]Search in Google Scholar
[14. Consortium TIS. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009; 460(7256): 748-752.10.1038/nature08185391283719571811]Search in Google Scholar
[15. Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D, et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry. 2012; 17(2): 142-153.10.1038/mp.2011.154360313422083728]Search in Google Scholar
[16. Raychaudhuri S, Korn JM, McCarroll SA, Altshuler D, Sklar P, Purcell S, et al. Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS Genet. 2010; 6(9): e1001097.10.1371/journal.pgen.1001097293652320838587]Search in Google Scholar
[17. Zaharieva I, Georgieva L, Nikolov I, Kirov G, Owen MJ, O’Donovan MC, et al. Association study in the 5q31-32 linkage region for schizophrenia using pooled DNA genotyping. BMC Psychiatry. 2008; 8: 11.10.1186/1471-244X-8-11226868718298822]Search in Google Scholar
[18. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet. 2005; 37(8): 853-862.10.1038/ng159816007088]Search in Google Scholar
[19. Jia J, Pekowska A, Jaeger S, Benoukraf T, Ferrier P, Spicuglia S. Assessing the efficiency and significance of Methylated DNA Immunoprecipitation (MeDIP) assays in using in vitro methylated genomic DNA. BMC Res Notes. 2010; 3: 240.10.1186/1756-0500-3-240294966220846371]Search in Google Scholar
[20. Down TA, Rakyan VK, Turner DJ, Flicek P, Li H, Kulesha E, et al. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol. 2008; 26(7): 779-785.10.1038/nbt1414264441018612301]Search in Google Scholar
[21. Liekens AM, De Knijf J, Daelemans W, Goethals B, De Rijk P, Del-Favero J. BioGraph: unsupervised biomedical knowledge discovery via automated hypothesis generation. Genome Biol. 2011; 12(6): R57.10.1186/gb-2011-12-6-r57321884521696594]Search in Google Scholar
[22. Watanabe M, Kanbara K. GABA and GABA Receptors in the Central Nervous System and Other Organs, vol. 213. San Diego, CA: Academic Press, 2002.10.1016/S0074-7696(02)13011-7]Search in Google Scholar
[23. Liu J, Morgan M, Hutchison K, Calhoun VD. A study of the influence of sex on genome wide methylation. PLoS One. 2010; 5(4): e10028.10.1371/journal.pone.0010028]Search in Google Scholar
[24. Canuso CM, Pandina G. Gender and schizophrenia. Psychopharmacol Bull. 2007; 40(4): 178-190.]Search in Google Scholar
[25. Bullock WM, Cardon K, Bustillo J, Roberts RC, Perrone-Bizzozero NI. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients. Am J Psychiatry. 2008; 165(12): 1594-1603.10.1176/appi.ajp.2008.07121845]Search in Google Scholar
[26. Nishioka M, Bundo M, Koike S, Takizawa R, Kakiuchi C, Araki T, et al. Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia. J Hum Genet. 2013; 58(2): 91-97.10.1038/jhg.2012.140]Search in Google Scholar
[27. Dempster EL, Pidsley R, Schalkwyk LC, Owens S, Georgiades A, Kane F, et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Molec Genet. 2011; 20(24): 4786-4796. 10.1093/hmg/ddr416]Search in Google Scholar
[28. Nakai T, Kitamura N, Hashimoto T, Kajimoto Y, Nishino N, Mita T, et al. Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia. Biol Psychiatry. 1991; 30(4): 349-356.10.1016/0006-3223(91)90290-3]Search in Google Scholar
[29. Lee ST, Ryu S, Kim SR, Kim MJ, Kim S, Kim JW, et al. Association study of 27 annotated genes for clozapine pharmacogenetics: validation of preexisting studies and identification of a new candidate gene, ABCB1, for treatment response. J Clin Psychopharmacol. 2012; 32(4): 441-448.10.1097/JCP.0b013e31825ac35c22722500]Search in Google Scholar
[30. Vehof J, Risselada AJ, Al Hadithy AF, Burger H, Snieder H, Wilffert B, et al. Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication. Psychopharmacology (Berlin). 2011; 216(2): 257-265.10.1007/s00213-011-2211-x312194621336576]Search in Google Scholar
[31. Gaughran F, Payne J, Sedgwick PM, Cotter D, Berry M. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain Res Bull. 2006; 70(3): 221-227.10.1016/j.brainresbull.2006.04.00816861106]Search in Google Scholar
[32. Bader V, Tomppo L, Trossbach SV, Bradshaw NJ, Prikulis I, Leliveld SR, et al. Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits. Hum Mol Genet. 2012; 21(20): 4406-4418.10.1093/hmg/dds273352958522798627]Search in Google Scholar
[33. Bornhauser BC, Olsson PA, Lindholm D. MSAP is a novel MIR-interacting protein that enhances neurite outgrowth and increases myosin regulatory light chain. J Biol Chem. 2003; 278(37): 35412-35420.10.1074/jbc.M306271200]Search in Google Scholar
[34. Hamajima N, Matsuda K, Sakata S, Tamaki N, Sasaki M, Nonaka M. A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution.Gene. 1996; 180(1-2): 157-163.10.1016/S0378-1119(96)00445-3]Search in Google Scholar
[35. Olsson PA, Korhonen L, Mercer EA, Lindholm D. MIR is a novel ERM-like protein that interacts with myosin regulatory light chain and inhibits neurite outgrowth. J Biol Chem. 1999; 274(51): 36288-36292.10.1074/jbc.274.51.3628810593918]Search in Google Scholar
[36. Soundararajan P, Fawcett JP, Rafuse VF. Guidance of postural motoneurons requires MAPK/ERK signaling downstream of fibroblast growth factor receptor 1. J Neurosci. 2010; 30(19): 6595-6606.10.1523/JNEUROSCI.4932-09.2010663257220463222]Search in Google Scholar
[37. Yamashita N, Uchida Y, Ohshima T, Hirai S, Nakamura F, Taniguchi M, et al. Collapsin response mediator protein 1 mediates reelin signaling in cortical neuronal migration. J Neurosci. 2006; 26(51): 13357-13362.10.1523/JNEUROSCI.4276-06.2006667499317182786]Search in Google Scholar
[38. Jarskog LF, Glantz LA, Gilmore JH, Lieberman JA. Apoptotic mechanisms in the pathophysiology of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2005; 29(5): 846-858.10.1016/j.pnpbp.2005.03.01015908096]Search in Google Scholar
[39. Kerns D, Vong GS, Barley K, Dracheva S, Katsel P, Casaccia P, et al. Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia. Schizophr Res. 2010; 120(1-3): 150-158.10.1016/j.schres.2010.04.01220580881]Search in Google Scholar
[40. Catts VS, Catts SV, McGrath JJ, Féron F, McLean D, Coulson EJ, et al. Apoptosis and schizophrenia: A pilot study based on dermal fibroblast cell lines. Schizophr Res. 2006; 84(1): 20-28.10.1016/j.schres.2006.03.01616626937]Search in Google Scholar
[41. Boston-Howes W, Gibb SL, Williams EO, Pasinelli P, Brown RH, Trotti D. Caspase-3 cleaves and inactivates the glutamate transporter EAAT2. J Biol Chem. 2006; 281(20): 14076-14084.10.1074/jbc.M60065320016567804]Search in Google Scholar
[42. Sari Y, Zhou FC. Prenatal alcohol exposure causes long-term serotonin neuron deficit in mice. Alcohol Clin Exp Res. 2004; 28(6): 941-948.10.1097/01.ALC.0000128228.08472.39]Search in Google Scholar
[43. Riedl SJ, Renatus M, Schwarzenbacher R, Zhou Q, Sun C, Fesik SW, et al. Structural basis for the inhibition of Caspase-3 by XIAP. Cell. 2001; 104(5): 791-800.10.1016/S0092-8674(01)00274-4]Search in Google Scholar
[44. Meynen G, Unmehopa UA, Hofman MA, Swaab DF, Hoogendijk WJ. Hypothalamic oxytocin mRNA expression and melancholic depression. Mol Psychiatry. 2007; 12(2): 118-119.10.1038/sj.mp.400191117252002]Search in Google Scholar
[45. Kyosseva SV. The role of the extracellular signal- regulated kinase pathway in cerebellar abnormalities in schizophrenia. Cerebellum. 2004; 3(2): 94-99.10.1080/1473422041002916415233576]Search in Google Scholar
[46. Lin DC, Quevedo C, Brewer NE, Bell A, Testa JR, Grimes ML, et al. APPL1 Associates with TrkA and GIPC1 and is required for nerve growth factor-mediated signal transduction. Mol Cell Biol. 2006; 26(23): 8928-8941.10.1128/MCB.00228-06163681517000777]Search in Google Scholar
[47. Yano H, Ninan I, Zhang H, Milner TA, Arancio O, Chao MV. BDNF-Mediated neurotransmission relies upon a myosin VI motor complex. Nat Neurosci. 2006; 9(8): 1009-1018. 10.1038/nn173016819522]Search in Google Scholar